Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic kidney ...

Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic Kidney Disease (PKD) Awareness Day, an initiative that aims to increase ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase I study titled ‘A Phase ...

Data from this Australian study showed a higher prevalence of intracranial aneurysms (ICAs) in patients with ADPKD compared with the general population. Many patients in the study had no known risk ...

Dapagliflozin improved eGFR slope in patients with CKD associated with ADPKD, but it resulted in an increase in kidney volume. Dapagliflozin may exert a protective effect on kidney function in ...

A large study of patients in the US Veterans Administration health system revealed that patients with ADPKD had a much higher rates of chronic obstructive pulmonary disease, hypertension, diabetes, ...

Please provide your email address to receive an email when new articles are posted on . Among patients with autosomal dominant polycystic kidney disease, outcomes were strongly associated with race ...

Please provide your email address to receive an email when new articles are posted on . Patients with autosomal dominant polycystic kidney disease have a preferable cardiac profile before ...

F inding out you have autosomal dominant polycystic kidney disease (ADPKD) can be a life-altering event, even if you haven’t yet experienced any symptoms. One of the most common genetic diseases, ...

Major complications occur in 7.0 percent of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic ...

The approach should be individualized to each patient, says Dr. David Charytan of the NYU Grossman School of Medicine. Here's why. (3:28) Before receiving a kidney transplant, patients with autosomal ...